mBC (4 GCT, Phase Ib/III & Phase III), BTC (2 GCT, Phase III), mCRC (1 study: Phase III), Gastric Cancer (1 study: Phase III), mCRPC (1 study: Phase IV), OC (1 study: Phase III, Patient PK study), Rotavirus (1 study: Phase III), Tdap (1 study: Phase II/III), Hexavalent (1 study: Phase I), T2DM (1 local trial, Phase III), Pre-diabetics (PK Study 1 study: PK), Transcatheter Aortic Valve Replacement (TAVR) (1 study: First-in Human), Peripheral Artery Disease (2 studies: First-in-Human), Coronary Artery Disease (3 studies in DES: 1 Registry and 2 Phase IV study), Vascular Closure Device (1 study, Post Marketing), Heart Failure (1 study: Phase III), Psoriasis (1 study: Phase III), Cognitive Function in Children (1 study), Cognitive Function in Children using CANTAB and fMRI (1 study), Total Knee Replacement (1 study: First-in-Human), Total Knee Joint Replacement (1 study: Post Marketing), Total Hip Replacement (1 study: Post Marketing), Acute Low Backache (1 study: Phase III), Joint Pain (2 study: Phase II and Phase III), Chronic OA (1 study: Phase IV, Thermal Imaging), Rheumatoid Arthritis (Phase III), Nutritional Supplement study in children (3 studies), Gingivitis (1 study: Global), Gum bleeding (1 study), Plaque calibration (1 study)